FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) held a virtual meeting on June 28, 2022, to publicly discuss whether a change to the current vaccine strain composition of COVID-19 vaccine booster doses is necessary for the 2022 fall and winter seasons.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BOofc9i
No comments:
Post a Comment